69 - Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks

On Demand

Participants should be aware of the following financial/non-financial relationships:

Eric Daar, MD: Bristol-Myers Squibb (Consultant)Gilead Sciences Inc. (Consultant, Scientific Research Study Investigator, Advisor or Review Panel member, Research Grant or Support)Janssen (Consultant, Advisor or Review Panel member, Research Grant or Support)Merck (Consultant, Advisor or Review Panel member, Research Grant or Support)Teva (Consultant, Advisor or Review Panel member)ViiV Healthcare (Consultant, Advisor or Review Panel member, Research Grant or Support)

Chloe Orkin, MD: Gilead Sciences Inc. (Grant/Research Support, Scientific Research Study Investigator, Other Financial or Material Support)Janssen (Research Grant or Support, Other Financial or Material Support)Merck (Research Grant or Support, Other Financial or Material Support)ViiV Healthcare (Research Grant or Support, Other Financial or Material Support)

Paul Sax, MD: Gilead Sciences (Consultant, Grant/Research Support)Janssen (Consultant)Merck (Consultant, Research Grant or Support)ViiV (Consultant, Research Grant or Support)

Jeffrey L. Stephens, MD: Gilead Sciences Inc. (Scientific Research Study Investigator, Research Grant or Support)

Ellen Koenig, MD: Gilead Sciences Inc. (Scientific Research Study Investigator)

Amanda Clarke, MD: Gilead Sciences Inc. (Consultant, Scientific Research Study Investigator, Other Financial or Material Support, Conference attendance sponsorship)ViiV Healthcare (Consultant, Other Financial or Material Support, Conference travel sponsorship)

Axel Baumgarten, MD: AbbVie (Advisor or Review Panel member, Speaker's Bureau)Bristol-Myers Squibb (Advisor or Review Panel member, Speaker's Bureau)Gilead Sciences Inc. (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)Janssen (Speaker's Bureau)Merck (Advisor or Review Panel member)

Cynthia Brinson, MD: Abbvie (Scientific Research Study Investigator)BI (Scientific Research Study Investigator)Gilead Sciences Inc. (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau, Personal fees)GSK (Scientific Research Study Investigator)Novo Nordisk (Scientific Research Study Investigator)ViiV Healthcare (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)

Moti Ramgopal, MD FIDSA: Abbvie (Scientific Research Study Investigator, Speaker's Bureau)Gilead (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Janssen (Consultant, Scientific Research Study Investigator, Research Grant or Support, Speaker's Bureau)Merck (Consultant, Scientific Research Study Investigator)ViiV (Consultant, Scientific Research Study Investigator, Speaker's Bureau)

Hailin Huang, PhD: Gilead Sciences Inc. (Employee, Shareholder)

Terry Farrow, MD: Gilead Sciences Inc. (Employee, Shareholder)

Jared Baeten, MD, PHD: Gilead Sciences Inc. (Employee, Shareholder)

Jason Hindman, PharmD: Gilead Sciences Inc. (Employee, Shareholder)

Hal Martin, MD, MPH: Gilead Sciences Inc. (Employee, Shareholder)

Kimberly Workowski, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

Eric Daar, MD

Investigator
The Lundquist Institute
Torrance, CA, United States

Bristol-Myers Squibb (Consultant)Gilead Sciences Inc. (Consultant, Scientific Research Study Investigator, Advisor or Review Panel member, Research Grant or Support)Janssen (Consultant, Advisor or Review Panel member, Research Grant or Support)Merck (Consultant, Advisor or Review Panel member, Research Grant or Support)Teva (Consultant, Advisor or Review Panel member)ViiV Healthcare (Consultant, Advisor or Review Panel member, Research Grant or Support)

Slides Slides and Audio

Co-Author(s)

CO

Chloe Orkin, MD

Barts Health NHS Trust, Royal London Hospital, Ambrose King Centre
London, England, United Kingdom

Gilead Sciences Inc. (Grant/Research Support, Scientific Research Study Investigator, Other Financial or Material Support)Janssen (Research Grant or Support, Other Financial or Material Support)Merck (Research Grant or Support, Other Financial or Material Support)ViiV Healthcare (Research Grant or Support, Other Financial or Material Support)
Paul Sax, MD

Clinical Director
Brigham and Women's Hospital
Boston, MA, United States

Gilead Sciences (Consultant, Grant/Research Support)Janssen (Consultant)Merck (Consultant, Research Grant or Support)ViiV (Consultant, Research Grant or Support)
JS

Jeffrey L. Stephens, MD

Professor and Chair of the Department
Mercer University School of Medicine
Macon, GA, United States

Gilead Sciences Inc. (Scientific Research Study Investigator, Research Grant or Support)
EK

Ellen Koenig, MD

MD
Instituto Dominicano de Estudio Virologicos – IDEV
Santo Domingo, Distrito Nacional, Dominican Republic

Gilead Sciences Inc. (Scientific Research Study Investigator)
AC

Amanda Clarke, MD

University Hospitals Sussex NHS Foundation
London, England, United Kingdom

Gilead Sciences Inc. (Consultant, Scientific Research Study Investigator, Other Financial or Material Support, Conference attendance sponsorship)ViiV Healthcare (Consultant, Other Financial or Material Support, Conference travel sponsorship)
AB

Axel Baumgarten, MD

Zentrum für Infektiologie Berlin Prenzlauer Berg
Berlin, Brandenburg, Germany

AbbVie (Advisor or Review Panel member, Speaker's Bureau)Bristol-Myers Squibb (Advisor or Review Panel member, Speaker's Bureau)Gilead Sciences Inc. (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)Janssen (Speaker's Bureau)Merck (Advisor or Review Panel member)
CB

Cynthia Brinson, MD

Medical Director
Central Texas Clinical Research
Austin, Texas, United States

Abbvie (Scientific Research Study Investigator)BI (Scientific Research Study Investigator)Gilead Sciences Inc. (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau, Personal fees)GSK (Scientific Research Study Investigator)Novo Nordisk (Scientific Research Study Investigator)ViiV Healthcare (Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)
MR

Moti Ramgopal, MD FIDSA

Chief Medical Officer
Midway Specialty Care Centers
Fort Pierce, Florida, United States

Abbvie (Scientific Research Study Investigator, Speaker's Bureau)Gilead (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Janssen (Consultant, Scientific Research Study Investigator, Research Grant or Support, Speaker's Bureau)Merck (Consultant, Scientific Research Study Investigator)ViiV (Consultant, Scientific Research Study Investigator, Speaker's Bureau)
HH

Hailin Huang, PhD

Gilead Sciences Inc.
Foster City, California, United States

Gilead Sciences Inc. (Employee, Shareholder)
TF

Terry Farrow, MD

Gilead Sciences Inc.
Foster City, California, United States

Gilead Sciences Inc. (Employee, Shareholder)
JB

Jared Baeten, MD, PHD

Gilead Sciences Inc.
Foster City, California, United States

Gilead Sciences Inc. (Employee, Shareholder)
JH

Jason Hindman, PharmD

Gilead Sciences Inc.
Foster City, California, United States

Gilead Sciences Inc. (Employee, Shareholder)
HM

Hal Martin, MD, MPH

Exec Director, Virology Clinical Research
Gilead Sciences Inc.
Foster City, California, United States

Gilead Sciences Inc. (Employee, Shareholder)
Kimberly Workowski, MD

Professor of Medicine, Division of Infectious Diseases
Emory University
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.